Sunday November 8, 2009 6:23 AM ET
SmartMoney
Net Asset Value: 
10.16
1-Day Return: 
0.02 (0.20%)
YTD Return
as of 11/6/09: 
Up 15.88%
FPHAX 
(Fidelity Sel Pharm)
Classification: Health/Biotech     Objective: Health/Biotech
Open to New Investors: Yes
Lipper Rating
Total Return
Consistent Return
Preservation
Tax Efficiency
Expense
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
NAV Chart | Growth of $10,000
Fund Chart
Total Returns (As of 11/06/2009)
 YTD1Yr3Yr5Yr10Yr
Fund 15.88 23.58 0.09 6.48NA
Classification 14.59 17.02 -1.33 3.01 6.37
Index (S&P 500) 20.90 21.30 -6.10 0.30 -0.70
% Rank in Class (1-best,100=worst)43213115NA
Fund Stats
Investment Objective:Health/Biotech
Net Assets ($Mil)172.40
Inception Date:6/18/01
Manager Name, TenureAndrew Oh, 2006
Expense Ratio: 1.00%
Sales Charge:
Load Type:
 
No Load
0.00%
0.00%
Top 10 Holdings (As of 8/31/09)
Company NameSymbol% Net Assets
Johnson & Johnson JNJ 15.89
Pfizer PFE 15.54
Merck MRK 9.25
Abbott Laboratories ABT 8.59
Schering Plough Corp SGP 4.94
Allergan Inc AGN 4.82
Bristol Myers BMY 2.35
Shire SHPGY 2.28
Vanda Pharmaceuticals Inc VNDA 2.10
Medco Health Sol MHS 1.74
% of Total Holdings 67.5
Advertisements
View Overview for: